In conclusion, our data demonstrate that the CD200 checkpoint exerts a more pervasive control of myeloid functions than previously thought and can act at the level of monocyte supply and recruitment thereby reducing atherosclerosis progression. Here, CD200 is linked to atherosclerosis.